doi:10.1016/j.jaad.2008.01.001 23Kantarjian H, Giles F, Wunderle L,
Chronic disease and chronic disease prevention are some of my passions, said Mavromatis, a former research fellow with an NIH training program
Because both drugs can affect the stomach and brain, the cumulative effect can be more noticeable initially
In patients in whom the major therapeutic goal is the compelling need to minimize the therapeutic risk pf hypoglycaemia, DPP-4 inhibitors are recommended as second line therapy after metformin failure at the same level as second line treatment options with GLP-1 receptor agonists, SGLT-2 inhibitors, or TZDs
These options are chosen after reviewing body mass index, waist circumference, blood sugar, blood pressure, liver health, medication history, and other factors